Cargando…

Histological improvement in chronic hepatitis B patients treated with bicyclol: real world experience

BACKGROUND: Bicyclol, the most commonly-used liver hepatoprotective drug in China, is often selected to control disease progression in CHB patients who refuse anti-viral treatment. However, data on histological changes after bicyclol treatment in these patients are scarce. Therefore, this study has...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chi, Xiaoling, Xiao, Huanming, Shi, Meijie, Cai, Gaoshu, Xie, Yubao, Jiang, Junmin, Tian, Guangjun, Wu, Shuduo, Zhang, Chaozhen, Zhao, Pengtao, Chen, Jiezhen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6567540/ https://www.ncbi.nlm.nih.gov/pubmed/31196030 http://dx.doi.org/10.1186/s12876-019-1005-1

Ejemplares similares

Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis
por: Xiao, Huanming, et al.
Publicado: (2017)

Effects of bicyclol on hepatic sinusoidal obstruction syndrome induced by Gynura segetum
por: Yao, Jianzuo, et al.
Publicado: (2022)

Prognostic Value of Inflammatory Indicators in Chronic Hepatitis B Patients With Significant Liver Fibrosis: A Multicenter Study in China
por: Zhang, Xiujuan, et al.
Publicado: (2021)

Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication
por: Huang, Meng-Hao, et al.
Publicado: (2019)

Research landscape and frontiers of non-alcoholic steatohepatitis-associated hepatocellular carcinoma: a bibliometric and visual analysis
por: Gao, Bowen, et al.
Publicado: (2023)

Protective Effect of Bicyclol on Anti-Tuberculosis Drug Induced Liver Injury in Rats
por: Liu, Xin, et al.
Publicado: (2017)

Effect of Bicyclol Tablets on Drug Induced Liver Injuries after Kidney Transplantation
por: Shang, Wenjun, et al.
Publicado: (2017)

Effect of bicyclol on blood biomarkers of NAFLD: a systematic review and meta-analysis
por: Li, Hu, et al.
Publicado: (2020)

Combined Use of Bicyclol and Berberine Alleviates Mouse Nonalcoholic Fatty Liver Disease
por: Li, Hu, et al.
Publicado: (2022)

Bicyclol Regulates Hepatic Gluconeogenesis in Rats with Type 2 Diabetes and Non-alcoholic Fatty Liver Disease by Inhibiting Inflammation
por: Li, Hongxue, et al.
Publicado: (2021)

A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol
por: Xie, Wen, et al.
Publicado: (2011)

WGCNA-Based Identification of Hub Genes and Key Pathways Involved in Nonalcoholic Fatty Liver Disease
por: Zeng, Folai, et al.
Publicado: (2021)

A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury
por: Naqiong, Wu, et al.
Publicado: (2017)

Bicyclol Attenuates Acute Liver Injury by Activating Autophagy, Anti-Oxidative and Anti-Inflammatory Capabilities in Mice
por: Zhao, Tian-Ming, et al.
Publicado: (2020)

Human Umbilical Cord Blood-Derived Mesenchymal Stem Cell Transplantation for Patients with Decompensated Liver Cirrhosis
por: Li, Zepeng, et al.
Publicado: (2023)

Bicyclol Attenuates Liver Inflammation Induced by Infection of Hepatitis C Virus via Repressing ROS-Mediated Activation of MAPK/NF-κB Signaling Pathway
por: Li, Hu, et al.
Publicado: (2018)

Compromise or not? A case report of successful treatment of pembrolizumab‐induced hepatitis in a patient with non‐small cell lung cancer with low‐dose methylprednisolone and bicyclol
por: Liu, Yan'e, et al.
Publicado: (2020)

A Novel Antihepatitis Drug, Bicyclol, Prevents Liver Carcinogenesis in Diethylnitrosamine-Initiated and Phenobarbital-Promoted Mice Tumor Model
por: Sun, Hua, et al.
Publicado: (2012)

Bicyclol for the treatment of drug-induced liver injury: a propensity score matching analysis using a nationwide inpatient database
por: Wang, Yongfeng, et al.
Publicado: (2021)

Author correction to ‘Up-regulation of glycolipid transfer protein by bicyclol causes spontaneous restriction of hepatitis C virus replication’ [Acta Pharmaceutica Sinica B 9 (2019) 769–781]
por: Huang, Meng-Hao, et al.
Publicado: (2020)

Regulating Nrf2-GPx4 axis by bicyclol can prevent ferroptosis in carbon tetrachloride-induced acute liver injury in mice
por: Zhao, Tianming, et al.
Publicado: (2022)

Bicyclol Alleviates Signs of BDL-Induced Cholestasis by Regulating Bile Acids and Autophagy-Mediated HMGB1/p62/Nrf2 Pathway
por: Zhao, Jingwen, et al.
Publicado: (2021)

Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Wu, Jingyi, et al.
Publicado: (2023)

Hepatitis Virus Reactivation in Patients with Psoriasis Treated with Secukinumab in a Real-World Setting of Hepatitis B or Hepatitis C Infection
por: Megna, Matteo, et al.
Publicado: (2022)

Erratum: Bicyclol attenuates high fat diet-induced non-alcoholic fatty liver disease/non-alcoholic steatohepatitis through modulating multiple pathways in mice
por: Frontiers Production Office,
Publicado: (2023)

Efficacy of chemotherapy for malignant pleural mesothelioma according to histology in a real-world cohort
por: Cedres, Susana, et al.
Publicado: (2021)

Patient Determinants for Histologic Diagnosis of NAFLD in the Real World: A TARGET‐NASH Study
por: Barritt, A. Sidney, et al.
Publicado: (2021)

The impact of ribavirin on real-world adherence rates in hepatitis C patients treated with sofosbuvir plus simeprevir
por: Walker, David R, et al.
Publicado: (2015)

Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
por: Aghemo, Alessio, et al.
Publicado: (2021)

Drug survival of biologics in treating psoriasis: a meta-analysis of real-world evidence
por: Lin, Pei-Tzu, et al.
Publicado: (2018)

Real‐world experience for the outcomes and costs of treating hepatitis C patients: Results from the German Hepatitis C-Registry (DHC-R)
por: Krüger, Kathrin, et al.
Publicado: (2022)

Real-world experience with histological confirmation of clinical response of squamous cell carcinoma to topical tirbanibulin
por: Moore, Angela, et al.
Publicado: (2023)

Real‐world use of endoscopic and histological indices in ulcerative colitis: Results of a global survey
por: Nardone, Olga Maria, et al.
Publicado: (2023)

Real-World Endoscopic and Histologic Outcomes in Ulcerative Colitis Patients: A Retrospective Cohort Study
por: State, Monica, et al.
Publicado: (2023)

Correction to: Real-World Outcomes in Historically Underserved Patients with Chronic Hepatitis C Infection Treated with Glecaprevir/Pibrentasvir
por: Aghemo, Alessio, et al.
Publicado: (2021)

Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World Cohorts
por: Forns, Xavier, et al.
Publicado: (2021)

Bicyclol induces cell cycle arrest and autophagy in HepG2 human hepatocellular carcinoma cells through the PI3K/AKT and Ras/Raf/MEK/ERK pathways
por: Wang, Yu, et al.
Publicado: (2016)

Blinatumomab for treating pediatric B-lineage acute lymphoblastic leukemia: A retrospective real-world study
por: Wu, Ying, et al.
Publicado: (2022)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

A real-world intention-to-treat analysis of a decade’s experience of treatment of hepatitis C with interferon-based therapies
por: Selvapatt, Nowlan, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ttvgk8qfe6lhari06uj0ogj384